Genprex Advances Diabetes Gene Therapy Manufacturing Scale-Up
AUSTIN, Texas, August 18, 2026 Genprex, Inc. has entered into a development and manufacturing agreement with a leading U.S.-based...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
AUSTIN, Texas, August 18, 2026 Genprex, Inc. has entered into a development and manufacturing agreement with a leading U.S.-based...
Charleston, South Carolina, August 12, 2026 Salus Scientific announced the launch of its Clinical Insights Series, a new publication...
Shanghai, China, August 12, 2026 Aurisco Pharmaceutical announced that its manufacturing site in Yangzhou, China, has successfully passed a...
ST. PAUL, Minnesota, August 11, 2026 Egg Medical, Inc., a medical technology company focused on radiation protection for healthcare...
WALNUT CREEK, California & SHANGHAI, China, August 11, 2026 Dark Horse Consulting Group (DHCG), a life sciences consulting organization...
Cambridge, Massachusetts – August 4, 2026 Moderna, Inc. has announced the initiation of a Phase 1 clinical trial evaluating...
Redmond, Washington, August 5, 2026 SystImmune, Inc., a clinical-stage biotechnology company and subsidiary of Biokin, has announced that the...
Plano, Texas & New York – August 3, 2026 Integer Holdings Corporation, one of the world’s largest medical device...
INCHEON, South Korea, July 20, 2026 Samsung Biologics has announced a landmark all-cash public tender offer to acquire 100%...
HAVERHILL, United Kingdom, July 6, 2026 Codis announced an agreement to acquire Catalent Pharma Solutions’ Nottingham, UK facility, a...
